FDA Warns Against Terbutaline for Preterm Labor
Links shared publicly online about this topic
FDA Warns Against Certain Uses Of Asthma Drug Terbutaline For Preterm Labor
medicalnewstoday.com — “The U.S. Food and Drug Administration is warning that terbutaline administered by injection or through an infusion pump should not be used in pregnant women for prevention or prolonged (beyond 48-” View full resource at medicalnewstoday.com
Most Recently Shared on February 18, 2011 at 4:07 pm By:
MNT Drug Approvals Health News
FDA Warns Against Certain Uses Of Asthma Drug Terbutaline For Preterm Labor http://mnt.to/3Rk6 #regulatory
FDA warns against terbutaline use for preterm labor - ONA
oncologynurseadvisor.com — “The FDA has notified healthcare professionals that injectable terbutaline should not be used in pregnant women for the prevention or prolonged treatment (beyond 48--72 hours) of preterm labor.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 17, 2011 at 7:08 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA warns against terbutaline use for preterm labor http://goo.gl/fb/X29hG
FDA warns against terbutaline use for preterm labor - MPR
empr.com — “The FDA has notified healthcare professionals that injectable terbutaline should not be used in pregnant women for the prevention or prolonged treatment (beyond 48--72 hours) of preterm labor.” View full resource at empr.com
Most Recently Shared on February 17, 2011 at 7:57 pm By:
MPR News: FDA warns against terbutaline use for preterm labor: The FDA has notified healthcare professionals tha... http://bit.ly/fLFPMd
FDA Alert: Terbutaline: Label Change - Warnings Against Use for Treatment of Preterm Labor
drugs.com — “FDA Alert: Terbutaline: Label Change - Warnings Against Use for Treatment of Preterm Labor” View full resource at drugs.com
Most Recently Shared on February 17, 2011 at 9:16 pm By:
FDA Alert - Label Change: Terbutaline - Warnings Against Use for Treatment of Preterm Labor - http://bit.ly/f24dyc
FDA Alert: Terbutaline: Label Change - Warnings Against Use for Treatment of Preterm Labor
drugs.com — “FDA Alert: Terbutaline: Label Change - Warnings Against Use for Treatment of Preterm Labor” View full resource at drugs.com
Most Recently Shared on February 17, 2011 at 10:16 pm By:
Drugs and Devices OW OW Health
Terbutaline: Label Change - Warnings Against Use for Treatment of Preterm Labor: Audience: OBGYN, Family Pr... http://bit.ly/dQ4TQO #FDA
FDA warns against terbutaline use by pregnant women - - Drug Topics
drugtopics.modernmedicine.com — “FDA notified healthcare professionals that neither injectable nor oral terbutaline be used by pregnant women for prevention of preterm labor due to risk of serious maternal heart problems and death.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on February 22, 2011 at 7:56 pm By:
Drugs and Devices OW OW Health
FDA warns against terbutaline use by pregnant women: FDA notified healthcare professionals that neither injectab... http://bit.ly/etV4y0
FDA Drug Safety Communication: New warnings against use of terbutaline to treat preterm labor - Drugs.com MedNews
drugs.com — “Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary References Safety Announcement 02-17-20” View full resource at drugs.com
Most Recently Shared on February 18, 2011 at 3:01 pm By:
Drugs and Devices OW OW Health
FDA Drug Safety Communication: New warnings against use of terbutaline to treat preterm labor: Safety Anno... http://bit.ly/edAPiA #drug
FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm... -- SILVER SPRING, Md., Feb. 17, 2011 /PRNewswire-USNewswire/ --
prnewswire.com — “FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm Labor.” View full resource at prnewswire.com
Most Recently Shared on February 17, 2011 at 8:28 pm By:
Michael Blaiss, MD Doctor, Allergist, and Physician
FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm http://t.co/w1ctXqQ
FDA requires stronger warning for pregnancy treatment terbutaline - Related Stories - AAP SmartBrief
smartbrief.com — “The FDA said terbutaline injections, which are used to help pregnant women avoid preterm labor, will carry a boxed warning. Injections should not be administered for longer than three days "because of the potential for serious maternal heart problems and death," the agency said. The FDA also advised” View full resource at smartbrief.com
Most Recently Shared on February 21, 2011 at 11:46 pm By:
Clara Song Pediatrician, Physician, and Doctor
FDA requires stronger warning for pregnancy treatment terbutaline http://sbne.ws/r/6NZB
Medical News: FDA Issues Warning on Asthma Drug in Preterm Labor - in OB/Gyn, Pregnancy from MedPage Today
medpagetoday.com — “WASHINGTON -- Injectable terbutaline should not be used to prevent preterm labor or to treat it beyond 48 to 72 hours because of a potential for cardiac problems or death, the FDA announced on Thursda” View full resource at medpagetoday.com
Most Recently Shared on February 17, 2011 at 7:50 pm By:
Hmmm was intuition the reason 4 my own noncompliance w/ terbutaline? FDA Issues Warning on Asthma Drug in Preterm Labor http://t.co/w58ejF6
FDA warns against asthma drug to delay premature birth - latimes.com
latimes.com — “Terbutaline doesn't prevent preterm labor and is linked to serious heart problems and death for mothers.” View full resource at latimes.com
Most Recently Shared on February 18, 2011 at 1:31 am By:
Dr. Poppy Daniels ObGyn Physician, Surgeon, Physician, and Doctor
Yeah, can we finally see the death of terbutaline for preterm labor! http://fb.me/w1lExvUm
Medical News: FDA Issues Warning on Asthma Drug in Preterm Labor - in OB/Gyn, Pregnancy from MedPage Today
medpagetoday.com — “WASHINGTON -- Injectable terbutaline should not be used to prevent preterm labor or to treat it beyond 48 to 72 hours because of a potential for cardiac problems or death, the FDA announced on Thursda” View full resource at medpagetoday.com
Most Recently Shared on February 17, 2011 at 8:01 pm By:
FDA Issues Warning on Asthma Drug in Preterm Labor http://bit.ly/hEvPuD
FDA warns against asthma drug to delay premature birth - latimes.com
latimes.com — “Terbutaline doesn't prevent preterm labor and is linked to serious heart problems and death for mothers.” View full resource at latimes.com
Most Recently Shared on February 18, 2011 at 12:49 am By:
LA Times Health News Health News
FDA warns against using asthma drug terbutaline to delay premature births http://lat.ms/fMm89W
FDA: Drug Used to Prevent Premature Labor Dangerous for Moms-to-Be - AOL Health
aolhealth.com — “The U.S. Food and Drug Administration is warning that a commonly used drug to prevent preterm labor may be dangerous for moms-to-be. In a statement i” View full resource at aolhealth.com
Most Recently Shared on February 18, 2011 at 4:42 pm By:
#FDA warning! The drug #terbutaline used to prevent preterm labor in #pregnant women may be extremely dangerous. http://aol.it/eX42Og
NursingCenter
nursingcenter.com — “. NursingCenter.com... Over 900 CE activities and thousands of clinical articles from over 50 leading Lippincott Williams & Wilkins nursing journals, including: The American Journal of Nursing, Nursing2007, Nursing Management, The Nurse Practitioner, Nursing Made Incredibly Easy, and many more specialty journals.” View full resource at nursingcenter.com
Most Recently Shared on February 18, 2011 at 4:17 pm By:
Lisa Morris Bonsall Nurse and Advanced Practice Nurse
FDA Warns Against Terbutaline for Preterm Labor http://bit.ly/dGjBER
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MNT Drug Approvals
The latest regulatory affairs / drug approvals news published daily. Articles from research centers, universities and prestigious journals.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
